|

ABP-745 Dose A Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Atom Therapeutics Co., Ltd1

Indications

  • Acute Gout Flare1
  • Gout Flares1
  • Gout Flare1
  • Acute Gouty Arthritis1
  • Arthritis1

Peoria, Arizona1 trial

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Onyx Clinical Research

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.